Skip to content
  • ABOUT US
    • What Do We Do?
    • Why Are We Better?
    • Senior Management
    • How To Contact Us
  • TRANSACTIONS
    • Chemical Transactions
    • Life Science Transactions
  • BROADCASTS & PUBLICATIONS
    • Our Broadcasts
    • Our Publications
    • Our Analyses
      • Chemical Industry Analyses
      • Pharmaceutical Industry Analyses
      • Biotechnology Industry Analyses
      • Medical Device Industry Analyses
  • CONFERENCES
    • Chemical Conferences
    • Life Science Conferences
  • INDUSTRY PORTALS
    • ChemicalIndustry.com
    • PharmaIndustry.com
    • MedicalDeviceIndustry.com
  • YOUNG & PARTNERS FORUM
  • ABOUT US
    • What Do We Do?
    • Why Are We Better?
    • Senior Management
    • How To Contact Us
  • TRANSACTIONS
    • Chemical Transactions
    • Life Science Transactions
  • BROADCASTS & PUBLICATIONS
    • Our Broadcasts
    • Our Publications
    • Our Analyses
      • Chemical Industry Analyses
      • Pharmaceutical Industry Analyses
      • Biotechnology Industry Analyses
      • Medical Device Industry Analyses
  • CONFERENCES
    • Chemical Conferences
    • Life Science Conferences
  • INDUSTRY PORTALS
    • ChemicalIndustry.com
    • PharmaIndustry.com
    • MedicalDeviceIndustry.com
  • YOUNG & PARTNERS FORUM

Our Publications

  • Our Broadcasts
  • Our Publications
  • Our Analyses
news2021-07-01T19:10:05+00:00

Chemical M&A – Reality vs Myth (Y&P article in ICIS Chemical Business) Oct 26 – Nov 1, 2018 issue

Young & Partners looks at the big picture trends, how they differ from conventional views, and their implications for management.

news2021-07-01T19:10:00+00:00

The Rise of China Biopharma (Pharmaceutical Executive – July issue)

Young & Partners analyzes the rise in China's biopharma industry, both positive and negative

news2021-07-01T19:09:54+00:00

Dr. Spielberg, former Deputy Commissioner of the FDA, joins Young & Partners (June 11, 2018)

Young & Partners adds to its deep regulatory and biopharma expertise

news2021-07-01T19:09:48+00:00

Banker: Value of Closed M&A Soars in 2017 due to Mega Deals (Feb 12 – 19, 2018, Chemical Week)

Peter Young of Young & Partners interviewed about the nuances of the Chemical M&A market in 2017

news2021-07-01T19:09:42+00:00

Stock Market and Financing – Strong with a Twist (ICIS Chemical Business, Feb 2, 2018 issue)

2017 was great for chemical stock market performance and financing, but not for everyone

news2021-07-01T19:09:36+00:00

Pharma and Biotech: Strategic, M&A and Financial Yearend Review and Outlook (Pharma Exec Feb 2018 issue)

Young & Partners reviews what happened in 2017, the future outlook and the implications for management

news2021-07-01T19:09:30+00:00

Chemical M&A – Below the Surface (ICIS Chemical Business, Jan 26, 2018 issue)

Young & Partners looks at the big picture trends and the nuances underneath

news2021-07-01T19:09:25+00:00

Chemical M&A and IPOs – A Warped View – Young & Partners (ICIS Chemical Business Nov. 10 – 16, 2017 issue)

Amid talk of a hot M&A market and IPOs, if you take a hard look at the numbers, reality is different

news2021-07-01T19:09:18+00:00

The Highs, Lows and the Unexpected – Young & Partners (ICIS Chemical Business Sept 8 – 14, 2017 issue)

Young & Partners' observations about chemical industry's stock market performance and financings (debt and equity)

news2021-07-01T19:09:02+00:00

Pharma and Biotech Markets (Young & Partners article in Pharma Executive eBook) Sept 2017

Young & Partners examines the biopharma stock market and M&A trends and their implications

Previous678Next

DISCLAIMER

JOIN OUR MAILING LIST

© YOUNG & PARTNERS LLC   |   535 Fifth Avenue, 4th Floor, New York, New York 10017 | 212-682-5555

Page load link
Go to Top